0000914190-17-000246.txt : 20170817 0000914190-17-000246.hdr.sgml : 20170817 20170817165018 ACCESSION NUMBER: 0000914190-17-000246 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170815 FILED AS OF DATE: 20170817 DATE AS OF CHANGE: 20170817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rosenstein Alexander CENTRAL INDEX KEY: 0001680771 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52082 FILM NUMBER: 171039155 MAIL ADDRESS: STREET 1: C/O CARDIOVASCULAR SYSTEMS, INC. STREET 2: 1225 OLD HIGHWAY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiovascular Systems Inc CENTRAL INDEX KEY: 0001180145 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411698056 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1225 OLD HWY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 BUSINESS PHONE: 651-259-1600 MAIL ADDRESS: STREET 1: 1225 OLD HWY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: REPLIDYNE INC DATE OF NAME CHANGE: 20020813 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-08-15 0001180145 Cardiovascular Systems Inc CSII 0001680771 Rosenstein Alexander 1225 OLD HIGHWAY 8 NW ST. PAUL MN 55112 0 1 0 0 General Counsel & Corp. Secy Common Stock 2017-08-15 4 S 0 255 30.7757 D 52296 D Common Stock 2017-08-16 4 S 0 724 30.6921 D 51572 D In connection with the vesting and delivery of restricted stock and pursuant to a Rule 10b5-1 trading plan, on the date the shares were sold the net proceeds were used to pay required withholding taxes. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.74 to $30.82 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.63 to $30.76 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Ashley Brosius as Attorney-in-Fact for Alexander Rosenstein pursuant to Power of Attorney previously filed. 2017-08-17